Work

Late Breaking Abstract - A first-in-human study of ARO-RAGE, an RNAi therapy designed to silence pulmonary RAGE expression

Year: 2023

Type: conference-abstract

DOI: 10.1183/13993003.congress-2023.oa2601

Authors: Mark O'Carroll, John Huetsch, James Hamilton, Lindsey Moser, Sudar Alagarsamy, Matthias Salathe

Institutions: Auckland City Hospital, Arrowhead Pharmaceuticals (United States), University of Kansas

Language: English

Topic: Advanced Glycation End Products research

Subfield: Clinical Biochemistry

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387979863

Cites:

Cited by: 6

Related to: 10